arrow
Back
N

Naga Chalasani

Indiana University

107H-index
848Paper Count
5.7WCitation Count
Published Papers 393
Publication Date
Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease
errCancers
IF4.4
err2026-08-28
err0
errOAAI
errAmit G. Singal; Mark Camardo; Janelle J. Bruinsma; Elle Kielar-Grevstad; Naga Chalasani; Binu V. John
errShare
errSave
Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia
err2026-08-27
err0
PREAI
errNaga Chalasani; Ismael Alvarez-Alvarez; Paul H. Hayashi; Raj Vuppalanchi; Marwan Ghabril; Ronald Kamusiime; Huiman Barnhart; Hao Niu; M. Isabel Lucena; Raul J. Andrade; for the Drug Induced Liver Injury Network
errShare
errSave
DRESS Syndrome in Patients With Drug-Induced Liver Injury: Characteristics and HLA Risk Factors
err2026-05-01
err3
PREAI
errRahnama-Moghadam, Sahand; Arora, Nitin; Vuppalanchi, Raj; Li, Yi Ju; Gu, Jiezhun; Barnhart, Huiman; Phillips, Elizabeth; Chalasani, Naga
errShare
errSave
Prevalence, Genetic Risks, and Cardiovascular Outcomes of Metabolic and Alcohol-Associated Liver Disease in a Longitudinal Multiethnic US Cohort
err2026-01-01
err0
PREAI
errYao, Jie; Guo, Xiuqing; Tan, Jingyi; Zaborenko, Callie; Rotter, Jerome, I; Chalasani, Naga P.
errShare
errSave
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
err2025-11-11
err0
PREAI
errMazen Noureddin; Stephen A Harrison; Rohit Loomba; Naim Alkhouri; Naga Chalasani; Muhammad Y Sheikh; Shaheen Tomah; Julio A Gutierrez; Silvia Urbina; John J Suschak; Randy Brown; Ozioma Odili; Jay Yang; Stephine Keeton; Guy Neff; Edward Mena; M Scot Roberts; Sarah K Browne; M Scott Harris
errShare
errSave
Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of Persons With HIV
err2025-11-01
err0
PREAI
errWegermann, Kara; Suzuki, Ayako; Sarmiento, Elisa; Boyd, Lakeisha; Li, Yang; Wilson, Laura A.; Lloyd, Audrey; Debroy, Paula; Price, Jennifer C.; Woreta, Tinsay; Crandall, Holly; Sterling, Richard K.; Loomba, Rohit; Chalasani, Naga; Lake, Jordan E.
errShare
errSave
The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus
err2025-10-01
err0
errOAAI
errSterling, Richard K.; Sternberg, Alice L.; Lake, Jordan E.; Naggie, Susanna; Heath, Sonya; Price, Jennifer C.; Wilson, Laura; Crandall, Holly; Gawrieh, Samer; Chalasani, Naga; Loomba, Rohit; Sulkowski, Mark
errShare
errSave
Genetic and non-genetic drivers of histological progression and regression in MASLD
err2025-09-24
err0
PREAI
errEduardo Vilar-Gomez; Katherine P. Yates; David E. Kleiner; Cynthia Behling; Oscar W. Cummings; Laura A. Wilson; Tiebing Liang; Chaowapong Jarasvaraparn; Rohit Loomba; Jeffrey B. Schwimmer; Arun J. Sanyal; Jay Hoofnagle; Naga Chalasani
errShare
errSave
Natural history and development of a novel composite endpoint in patients with alcohol-associated hepatitis: Data from a prospective multicenter study
err2025-09-01
err3
PREAI
errDasarathy, Srinivasan; Tu, Wanzhu; Welch, Nicole; Gawrieh, Samer; Yu, Yunpeng; Tang, Qing; Kettler, Carla; Sanyal, Arun J.; Szabo, Gyongyi; Shah, Vijay H.; Bataller, Ramon; Nagy, Laura E.; Mcclain, Craig J.; Chalasani, Naga; Kerr, Thomas; Mitchell, Mack C.
errShare
errSave
Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States
err2025-08-27
err0
PREAI
errEduardo Vilar-Gomez; Lauren Nephew; Samer Gawrieh; Raj Vuppalanchi; Carla Kettler; Francis Pike; Wanzhu Tu; Niharika Samala; Suthat Liangpunsakul; Naga Chalasani
errShare
errSave
Biological age, PNPLA3 and risk of metabolic dysfunction-associated steatotic liver disease
err2025-08-25
err0
PREAI
errSamer Gawrieh; Jie Yao; Xiuqing Guo; Anna Mae Diehl; Jerome I. Rotter; Naga P. Chalasani
errShare
errSave
Social Determinants Are Important Barriers to Completion of the Liver Transplant Pathway and Are Associated with Waitlisting and Mortality in Hepatocellular Carcinoma
err2025-08-06
err0
errOAAI
errBrittany Baker; Tarek G. Aridi; Meera Patel; Allie Carter; Carolyn Singleton; Katie Ross-Driscoll; Eric Orman; Archita P. Desai; Marwan Ghabril; Naga Chalasani; Shekhar Kubal; John Holden; Lauren D. Nephew
errShare
errSave
Information overload, financial constraints, and psychological burdens are among the barriers faced by marginalized groups seeking curative treatments for HCC
err2025-03-01
err0
errOAAI
errNephew, Lauren D.; Moore, Courtney; Garcia, Nicole; Parks, Lisa; Mckay, Allison; Strauss, Alexandra T.; Wiehe, Sara; Chalasani, Naga; Hughes-Wegner, Alexandra T.; Rawl, Susan M.
errShare
errSave
Drug-Induced Liver Injury in Patients With Chronic Liver Disease
err2025-02-10
err0
errOAAI
errGhabril, Marwan; Vuppalanchi, Raj; Chalasani, Naga
errShare
errSave
Short-term costs of alcohol-associated hepatitis care in different clinical settings
err2025-02-01
err0
errOAAI
errNguyen, Chi Mai; Su, Jing; Li, Yang; Healey, Ryan; Jiang, Shihui; Li, Jiangqiong; Chalasani, Naga; Gawrieh, Samer; Liangpunsakul, Suthat; Tu, Wanzhu
errShare
errSave
Clinical decision instruments for predicting mortality in patients with cirrhosis seeking emergency department care
err2025-01-08
err0
errOAAI
errParvataneni, Swetha; Haugh, Michelle; Sarkis, Yara; Baker, Brittany; Nephew, Lauren D.; Ghabril, Marwan S.; Vuppalanchi, Raj; Orman, Eric S.; Chalasani, Naga P.; Desai, Archita P.; Harrison, Nicholas Eric
errShare
errSave
MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics
err2024-10-17
err1
errOAAI
errLin, Kung-Hung; Vilar-Gomez, Eduardo; Corey, Kathleen E.; Connelly, Margery A.; Gupta, Samir K.; Lake, Jordan E.; Chalasani, Naga; Gawrieh, Samer
errShare
errSave